Table 5.
HPV DNA prevalence for oropharyngeal, oral cavity, and laryngeal cancer diagnosed in Ireland between 1994 and 2013.
| Sub-Site | Fraction | Prevalence |
|---|---|---|
| Oropharynx | 86/209 | 41.1% |
| Oral Cavity | 36/331 | 10.9% |
| Larynx | 25/321 | 7.8% |
| All | 147/861 | 17.1% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.